Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias - PubMed (original) (raw)
. 2000 Jul 19;92(14):1151-8.
doi: 10.1093/jnci/92.14.1151.
Affiliations
- PMID: 10904088
- DOI: 10.1093/jnci/92.14.1151
Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias
S Wacholder et al. J Natl Cancer Inst. 2000.
Abstract
Background: Some critics argue that bias from population stratification (the mixture of individuals from heterogeneous genetic backgrounds) undermines the credibility of epidemiologic studies designed to estimate the association between a genotype and the risk of disease. We investigated the degree of bias likely from population stratification in U.S. studies of cancer among non-Hispanic Caucasians of European origin.
Methods: An expression of the confounding risk ratio-the ratio of the effect of the genetic factor on risk of disease with and without adjustment for ethnicity-is used to measure the potential relative bias from population stratification. We first use empirical data on the frequency of the N-acetyltransferase (NAT2) slow acetylation genotype and incidence rates of male bladder cancer and female breast cancer in non-Hispanic U.S. Caucasians with ancestries from eight European countries to assess the bias in a hypothetical population-based U.S. study that does not take ethnicity into consideration. Then, we provide theoretical calculations of the bias over a large range of allele frequencies and disease rates.
Results: Ignoring ethnicity leads to a bias of 1% or less in our empirical studies of NAT2. Furthermore, evaluation of a wide range of allele frequencies and representative ranges of cancer rates that exist across European populations shows that the risk ratio is biased by less than 10% in U.S. studies except under extreme conditions. We note that the bias decreases as the number of ethnic strata increases.
Conclusions: There will be only a small bias from population stratification in a well-designed case-control study of genetic factors that ignores ethnicity among non-Hispanic U.S. Caucasians of European origin. Further work is needed to estimate the effect of population stratification within other populations.
Comment in
- Re: Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias.
Millikan RC. Millikan RC. J Natl Cancer Inst. 2001 Jan 17;93(2):156-8. doi: 10.1093/jnci/93.2.156. J Natl Cancer Inst. 2001. PMID: 11208892 No abstract available.
Similar articles
- Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention.
Loktionov A, Moore W, Spencer SP, Vorster H, Nell T, O'Neill IK, Bingham SA, Cummings JH. Loktionov A, et al. Cancer Detect Prev. 2002;26(1):15-22. doi: 10.1016/s0361-090x(02)00010-7. Cancer Detect Prev. 2002. PMID: 12088198 - Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer.
Deitz AC, Rothman N, Rebbeck TR, Hayes RB, Chow WH, Zheng W, Hein DW, García-Closas M. Deitz AC, et al. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1543-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342459 - Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J, Liang D, Wang Y, Lu C, Wu X. Gu J, et al. Mutat Res. 2005 Mar 7;581(1-2):97-104. doi: 10.1016/j.mrgentox.2004.11.012. Epub 2004 Dec 16. Mutat Res. 2005. PMID: 15725609 - Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Hein DW, et al. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667461 Review. - Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
Wu H, Wang X, Zhang L, Mo N, Lv Z. Wu H, et al. Clin Genitourin Cancer. 2016 Apr;14(2):122-9. doi: 10.1016/j.clgc.2015.10.007. Epub 2015 Oct 26. Clin Genitourin Cancer. 2016. PMID: 26585839 Review.
Cited by
- Causal factors for osteoarthritis risk revealed by mendelian randomization analysis.
Luo Q, Zhang S, Yang Q, Deng Y, Yi H, Li X. Luo Q, et al. Aging Clin Exp Res. 2024 Aug 22;36(1):176. doi: 10.1007/s40520-024-02812-9. Aging Clin Exp Res. 2024. PMID: 39172202 Free PMC article. Review. - Candidate-gene association analysis for a continuous phenotype with a spike at zero using parent-offspring trios.
Klein N, Entwistle A, Rosenberger A, Kneib T, Bickeböller H. Klein N, et al. J Appl Stat. 2019 Dec 19;47(11):2066-2080. doi: 10.1080/02664763.2019.1704226. eCollection 2020. J Appl Stat. 2019. PMID: 35707573 Free PMC article. - The total and direct effects of systolic and diastolic blood pressure on cardiovascular disease and longevity using Mendelian randomisation.
Chan II, Kwok MK, Schooling CM. Chan II, et al. Sci Rep. 2021 Nov 8;11(1):21799. doi: 10.1038/s41598-021-00895-2. Sci Rep. 2021. PMID: 34750372 Free PMC article. - PTGDR2 Expression in Peripheral Blood as a Potential Biomarker in Adult Patients with Asthma.
García-Sánchez A, Estravís M, Martin MJ, Pérez-Pazos J, Martín-García C, Gil-Melcón M, Ramos-González J, Eguiluz-Gracia I, Triviño JC, Isidoro-García M, Dávila I, Sanz C. García-Sánchez A, et al. J Pers Med. 2021 Aug 24;11(9):827. doi: 10.3390/jpm11090827. J Pers Med. 2021. PMID: 34575604 Free PMC article. - Adiposity and cancer: a Mendelian randomization analysis in the UK biobank.
Ahmed M, Mulugeta A, Lee SH, Mäkinen VP, Boyle T, Hyppönen E. Ahmed M, et al. Int J Obes (Lond). 2021 Dec;45(12):2657-2665. doi: 10.1038/s41366-021-00942-y. Epub 2021 Aug 27. Int J Obes (Lond). 2021. PMID: 34453097
MeSH terms
Substances
LinkOut - more resources
Full Text Sources